A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants
Clinical trial NCT03564379 · COMPLETED
Trial details
- NCT number
- NCT03564379
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2018-08-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.